Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Andreas Sashegyi
On the Interpretation of the Hazard Ratio and Communication of Survival Benefit
Oncologist
Cancer Research
Medicine
Oncology
Outcomes in Patients With Aggressive or Refractory Disease From REVEL, a Randomized Phase III Study of Docetaxel With Ramucirumab or Placebo for Second-Line Treatment of Stage IV Non-Small-Cell Lung Cancer
Lung Cancer
Cancer Research
Oncology
Respiratory Medicine
Pulmonary
Related publications
Limitations of the Incidence Density Ratio as Approximation of the Hazard Ratio
Trials
Medicine
Pharmacology
Quantifying the Cost and Benefit of Latency Insensitive Communication on FPGAs
Pcn58 - Median Survival, Mean Survival or Hazard Ratio: Which Endpoint Is the Most Appropriate for Patients, Physicians and Policy Makers?
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
The Period and Nature of Hazard in Clinical Renal Transplantation. I. The Hazard to Patient Survival
Transplantation
Transplantation
Maximizing the Benefit of Existing Equipment for Nonlinear and Communication Measurements
System Interpretation of Stage Communication
Vestnik Tomskogo gosudarstvennogo universiteta. Kul'turologiya i iskusstvovedenie
Geometric Method of Determining Hazard for the Continuous Survival Function
Folia Oeconomica Stetinensia
A New Interpretation of the High Energy Atmospheric Muon Charge Ratio
Journal of Physics: Conference Series
Astronomy
Physics
The TLNO/TLCO Ratio in Pulmonary Function Test Interpretation
European Respiratory Journal
Medicine
Pulmonary
Respiratory Medicine
